Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

ver descrição completa

Detalhes bibliográficos
Main Authors: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2023-12-01
Colecção:Biomarkers in Neuropsychiatry
Assuntos:
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2666144623000102